US Health Department Proposes Changes to Drug Pricing and Federal Healthcare Procurement\
The Department of Health and Human Services has proposed regulatory changes intended to increase transparency in pharmaceutical pricing and restructure federal healthcare purchasing procedures. The proposals also seek to expand direct-to-consumer health insurance options, potentially changing how healthcare services and insurance products are purchased and offered in the United States.